Anti-CD40L monoclonal antibody treatment induces long-term, tissue-specific, immunologic hyporesponsiveness to peripheral nerve allografts

Journal of Reconstructive Microsurgery

Volumn 24, Issue 3, 2008, Pages 189-195

  Mungara, Anil K ^a   Brown, David L ^a   Bishop, D Keith ^b   Wood, Sherri Y ^b   Cederna, Paul S ^a,c,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Anti CD40L mAb; MR1; Nerve allograft

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ALLOGRAFT; ANIMAL EXPERIMENT; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; GRAFT REJECTION; IMMUNE RESPONSE; MOUSE; NERVE GRAFT; NERVE TRANSPLANTATION; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TISSUE SPECIFICITY;

ANIMALS; ANTIBODIES, MONOCLONAL; CD40 LIGAND; CYTOKINES; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SCIATIC NERVE; TRANSPLANTATION, HOMOLOGOUS;

EID: 45249084763     PISSN: 0743684X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1076085     Document Type: Article

References (37)

1. Mackinnon SE. Nerve allotransplantation following severe tibial nerve injury. Case report. J Neurosurg 1996;84:671-676
2. Mackinnon SE, Doolabh VB, Novak CB, Trulock EP. Clinical outcome following nerve allograft transplantation. Plast Reconstr Surg 2001;107:1419-1429
3. Hare GM, Evans PJ, Mackinnon SE, et al. Effect of cold preservation on lymphocyte migration into peripheral nerve allografts in sheep. Transplantation 1993;56:154-162
4. Sondell M, Lundborg G, Kanje M. Regeneration of rat sciatic nerve into allografts made acellular through chemical extraction. Brain Res 1998;795:44-54
5. MacKinnon SE, Hudson AR. Clinical application of peripheral nerve transplantation. Plast Reconstr Surg 1992;90:695-699
6. Lassner F, Schaller E, Steinhoff G, Wonigeit K, Walter GF, Berger A. Cellular mechanisms of rejection and regeneration in peripheral nerve allografts. Transplantation 1989;48:386-392
7. Midha R, Mackinnon SE, Becker LE. The fate of Schwann cells in peripheral nerve allografts. J Neuropathol Exp Neurol 1994;53:316-322
8. Atchabahian A, Genden EM, Mackinnon SE, Doolabh VB, Hunter DA. Regeneration through long nerve grafts in the swine model. Microsurgery 1998;18:379-382
9. Best TJ, Mackinnon SE, Midha R, Hunter DA, Evans PJ. Revascularization of peripheral nerve autografts and allografts. Plast Reconstr Surg 1999;104:152-160
10. Trumble TE, Shon FG. The physiology of nerve transplantation. Hand Clin 2000;16:105-122
11. Ansselin AD, Pollard JD. Immunopathological factors in peripheral nerve allograft rejection: quantification of lymphocyte invasion and major histocompatibility complex expression. J Neurol Sci 1990;96:75-78
12. Rovak JM, Bishop DK, Boxer LK, Wood SC, Mungara AK, Cederna PS. Peripheral nerve transplantation: the role of chemical acellularization in eliminating allograft antigenicity. J Reconstr Microsurg 2005;21:207-213
13. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 1997;94:8789-8794
14. Elster EA, Blair PJ, Kirk AD. Potential of co-stimulation based therapies for composite tissue allotransplantation. Microsurgery 2000;20:430-434
15. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996;381:434-438
16. Pierson RN, Chang AC, Blum MG, et al. Prolongation of primate cardiac allograft survival by treatment with anti-CD40 ligand (CD154) antibody. Transplantation 1999;68:1800-1805
17. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994;15:406-411
18. Yamada A, Sayegh MH. The CD154-CD40 costimulatory pathway in transplantation. Transplantation 2002;73:S36-S39
19. Jones ND, Van Maurik A, Hara M, et al. CD40-CD40 ligand independent activation of CD8 + T cells can trigger allograft rejection. J Immunol 2000;165:1111-1118
20. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998;338:1813-1821
21. Sun H, Subbotin V, Chen C, et al. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation 1997;64:1838-1843
22. Kirk AD, Burkly LC, Batty DS, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999;5:686-693
23. Kenyon NS, Chatzipetrou M, Masetti M, et al. Long term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A 1999;96:8132-8137
24. Nathan MJ, Yin D, Eichwald EJ, Bishop DK. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells. Am J Transplant 2002;2:323-332
25. Guillot C, Guillonneau C, Mathieu P, et al. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long term heart allograft survival and donor specific hyporesponsiveness, but does not prevent chronic rejection. J Immunol 2002;168:1600-1609
26. Matesic D, Lehmann PV, Heeger PS. High resolution characterization of cytokine producing alloreactivity in naïve and allograft primed mice. Transplantation 1998;65:906-914
27. Brown DL, Bishop DK, Wood SY, Cederna PS. Short-term anti-CD40 ligand costimulatory blockade induces tolerance to peripheral nerve allografts, resulting in improved skeletal muscle function. Plast Reconstr Surg 2006;117:2250-2258
28. Shepherd DM, Kerkvliet NI. Disruption of CD154:CD40 blocks regeneration of allograft immunity without affecting APC activation. J Immunol 1999;163:2470-2477
29. Bishop DK, Wood S, Eichwald E, Orosz C. Immunobiology of allograft rejection in the absence of INF-γ: CD8 + effector cells develop independently of CD4 + cells and CD40-CD40 ligand interactions. J Immunol 2001;166:3248-3255
30. Azuma H, Chandraker A, Nadeau K. Blockade of T cell costimulation prevents development of experimental chronic allograft rejection. Proc Natl Acad Sci U S A 1996;93:12439-12444
31. Graca L, Honey K, Adams E, Cobbold S, Waldmann H. Cutting edge: anti-CD154 therapeutic antibodies induce infectious tolerance. J Immunol 2000;165:4783-4786
32. Li Y, Li XC, Zheng A, et al. Blocking both signal 1 and signal 2 of T cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999;5:1298-1302
33. Wells AD, Li XC, Li Y, et al. Requirement for T cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999;5:1303-1307
34. Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8 + T cells and prolonged graft survival in a CTA4-dependent manner. J Immunol 2000;164:512-521
35. Ensminger SM, Witzke O, Spriewald BM, et al. CD8 + T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade. Transplantation 2000;69:2609-2612
36. Evans PJ, Mackinnon SE, Midha R, et al. Regeneration across cold preserved peripheral nerve allografts. Microsurgery 1999;19:115-127
37. Bain JR. Peripheral nerve and neuromuscular allotransplantation: current status. Microsurgery 2000;20:384-388